Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience.
Clinical Features and Outcomes of 23 Patients with Wiskott-Aldrich Syndrome: A Single-Center Experience.
复制标题
DOI:
10.4274/tjh.galenos.2020.2020.0334
复制
发表时间:
2020-11-19
期刊:
影响因子:
--
通讯作者:
İkincioğulları A
中科院分区:
文献类型:
--
作者:
Haskoloğlu Ş;Öztürk A;Öztürk G;Kostel Bal S;İslamoğlu C;Baskın K;Ceylaner S;Tufan Satıroğlu L;Doğu F;İkincioğulları A
Wiskott-Aldrich syndrome (WAS) is an X-linked primary immune deficiency characterized by microthrombocytopenia, eczema, and recurrent infections. We aimed to evaluate the clinical features and outcomes of a WAS cohort. We retrospectively evaluated the clinical courses, immunological features, treatments, and outcomes in a total of 23 WAS patients together with data related to 11 transplanted cases among them between 1982 and 2019. Before admission, 11 patients (48%) were misdiagnosed with immune thrombocytopenia. WAS scores were mostly 4 or 5. Eleven patients were transplanted and they had an overall survival rate of 100% during a median follow-up period of 8.5 years (range: 8 months to 20 years). Five patients who were not transplanted died at a median of 7 years (range: 2-26 years). Nontransplanted patients had high morbidity due to organ damage, mostly caused by autoimmunity, bleeding, and infections. Two novel mutations were also defined. All male babies with microthrombocytopenia should be evaluated for WAS. Hematopoietic stem cell transplantation should be performed at the earliest age with the best possible donors.
登录
查看更多内容
影响因子:
3.2
作者:
Notarangelo, Luigi D.;Miao, Carol H.;Ochs, Hans D.
通讯作者:
Ochs, Hans D.
影响因子:
20.3
作者:
Filipovich, AH;Stone, JV;Horowitz, MM
通讯作者:
Horowitz, MM
影响因子:
20.3
作者:
Imai, K;Morio, T;Nonoyama, S
通讯作者:
Nonoyama, S
影响因子:
14.2
作者:
Elfeky, Reem Ahmed;Furtado-Silva, Juliana M.;Veys, Paul
通讯作者:
Veys, Paul
影响因子:
20.3
作者:
Ozsahin, Hulya;Cavazzana-Calvo, Marina;Fischer, Alain
通讯作者:
Fischer, Alain